From eNewsletter 10/20/2021
DID YOU KNOW that we felt an enormous amount of vindication after last week's about face from The United States Preventive Services Task Force regarding aspirin? "The USPSTF concludes with moderate certainty that initiating aspirin use for the primary prevention of CVD events in adults age 60 years or older has no net benefit," the task force concluded in a complete reversal going back decades. We have consistently told our clients that in this age group, taking aspirin preventively was unnecessary and potentially dangerous. We know that public health changes move at a glacial pace, but the immeasurable damage done to older persons during this time is incalculable. The shame of it all is that the research was there all along, but simply ignored. Please make your doctors aware if they still unknowingly push aspirin on you.
Carlson Mini Multi After a long stint on the out of stock list, Carlson Mini Multi is available again.
Food Intolerance Test Blood Draw Update Next available Saturday blood draw date for the Biotrition food intolerance test is November 20th.
Text Us To better serve your needs, we now have the ability to accept text messages. Simply type in (847) 498-3422 and text away!
UPDATE - COVID-19 Vaccine Information We updated this document Monday, October 18th.
Virus Prevention And Treatment Vaccines will minimize COVID-19 related mortality and hospitalizations, but SARS-CoV-2 is not going away, as evidenced by its ever-mutating variants. Moreover, SARS-CoV-2 is not the only virus we fight. There are influenza (flu), norovirus (stomach flu), adenovirus (common cold), and four other coronaviruses (common cold), among others.We highly recommend continuing your immune support. For more information, refer to our Prevent and Fight Viruses 2.0 Protocol.
COVID-19 Condition Monograph For those interested in conventional and integrative treatments for COVID-19 with over 250 references, this is our COVID-19 Condition Monograph.
Post-COVID Syndrome The official diagnosis for post-COVID syndrome (PCS) are symptoms that last for 12 weeks or more. If you, a family member, friend, coworker, or neighbor is suffering from PCS, diligently following our Post-COVID Syndrome Action Plan for purchase, or free to paid members here, can bring measurable improvement.
Have a happy, healthy day! Steve and Bonnie Minsky
In Today's Issue...
Well Connect Feature: Bonnie on Beans*
October 20% OFF Sale Items
Chiro Corner NEW!
Pure Genomics 2.0
Well Connect Member Benefits *Paid Member Access Only
Steve and Bonnie: Consternation abounds when discussing myocarditis (heart inflammation) in young persons (between 18 and 30) who received the mRNA vaccine. Some are skeptical of the CDC and FDA data/recommendations, even though they added a mycocarditis warning on the label. The first truly independent study on this issue, appearing in JAMA Internal Medicine, examined over 2 million persons in the Kaiser Permanente medical system. The authors did not receive any government grants and had no connection to government bodies. The conclusion was pretty much we've said from the beginning about this issue. After one dose, myocarditis is very rare (5.8 per 1 million persons). After the second dose, based upon the current 3 week schedule, the risk goes up significantly (1 in 172,414 persons). Thus, in young persons, one dose should be sufficient or, the distance between the first and second dose should be six weeks minimum, but ideally 8-12 weeks. The other thing that has not been discussed or researched is something we have said to our young clients who get the vaccine. Rigorous physical activity must be eliminated for 2-3 days after each vaccine dose. As the immune system is priming post-vaccination, adding intense physical activity can lead to acute inflammation, and can affect the heart. Thus, any young person getting the vaccine should do no more than walk for 2-3 days afterwards. Histamine There's a reason we recommend taking an antihistamine prior to getting the mRNA vaccine. This is to mitigate excess mast cell production (which leads to excess histamine production), which create stronger symptoms, sometimes anaphylaxis. A new study from Nutrients found that COVID-19 also creates excess histamine production, which can lead to unmitigated inflammation. This is why nutrients such as quercetin, vitamin C, zinc, glutathione are recommended in our protocol. As more research becomes available, it is possible that adding an antihistamine and DAO enzyme (which breaks down food-related histamine) may also be warranted for those who get COVID-19. Alternative Vaccine Delivery Systems Researchers reporting in ACS Nano have developed a microneedle patch that delivers a COVID-19 DNA vaccine into the skin, causing strong immune responses in cells and mice. Importantly, the patch can be stored for over 30 days at room temperature. Researchers from three US universities received a $500,000 grant from the National Science Foundation to find way to grow edible plants that carry the same medication as an mRNA vaccine. Vagus Nerve Stimulation Non-invasive vagus nerve stimulation (nVNS) therapy led to significant reductions in levels of inflammatory markers, specifically C-reactive protein and procalcitonin. Because nVNS has multiple mechanisms of action that may be relevant to COVID-19, additional research into its potential to be used earlier in the course of COVID-19 and possibly mitigate some of the symptoms associated with post-acute COVID-19 syndrome is in the works, according to this study from Medrxiv. Vaccine and Long Haulers Another study, this from The Lancet, revealed that mRNA vaccination lowers the intensity and life impact of long COVID among patients with persistent symptoms. In the placebo-controlled trial, subjects who received the vaccine reported significantly higher rates of remission, less overall impact of symptoms on daily life, and much less unacceptable symptoms rate. Gut Dysbiosis According to a new study in Medrxiv, COVID-19 severity is greatly increased in those with gut dysbiosis, which means an imbalance in gut microflora. HEPA Filter High-efficiency particulate air (HEPA) filters and ultraviolet (UV) light sterilization effectively remove SARS-CoV-2 particles from the air, the first such evidence in a real-world test, researchers report in Medrxiv. The journal Nature also reported research suggesting the filters may help reduce the risk of hospital-acquired SARS-CoV-2.